Barclays’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Barclays’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-68,700	Closed	-$695K	–	5486
2022 Q3	$695K	Hold	68,700	–	–	﹤0.01%	2477
2022 Q2	$690K	Hold	68,700	–	–	﹤0.01%	2631
2022 Q1	$688K	Buy	+68,700	New	+$687K	﹤0.01%	2675

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays's ARCK Position: Q4 2022 in Review

Barclays sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 68,700 shares — an estimated $695K sold.

Barclays first reported a position in ARCK in Q1 2022 and held it in 3 quarters. The position peaked at $695K in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Barclays reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Barclays sold 68,700 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $695K.
Barclays first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
Barclays's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $695K in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.